Skip to main content

Advertisement

Table 1 Characteristics of patients

From: Limited cross-border infections in patients newly diagnosed with HIV in Europe

Characteristics Categories Total patients
Patients   4260
Continent of Origin, no. (%) Western Europe 2361 (55.4)
Eastern Europe & Central Asia 915 (21.5)
Sub-Saharan Africa 467 (11.0)
Other 517 (12.1)
Baseline values HIV-RNA load, mean (IQR), log copies/ml 4.8 (4.3-5.3)
CD4 cell count, median (IQR), cells/mm3 354 (181–540)
Age, mean years (IQR) 36.3 (29–42)
Gender, no. (%) male 3361 (78.9)
Risk group, no. (%) Men having Sex with Men (MSM) 2061 (48.4)
Heterosexual contact 1477 (34.7)
Injection drug use 347 (8.1)
Other 39 (0.9)
unknown 336 (7.9)
CDC stage, no. (%) A and B 3537 (83.0)
C 516 (12.1)
Subtype, no. (%) B 2820 (66.2)
A 477 (11.2)
C 291 (6.8)
02_AG 197 (4.6)
G 137 (3.2)
F 92 (2.2)
others 167 (3.9)
unassigned 79 (1.9)
non-B 1361 (31.9)
Duration of infection, no. (%) <1 year 1228 (28.8)
1-2 years 141 (3.3)
Unknown duration 2891 (67.9)
TDRM, no. (%) present 380 (8.9)
  1. NOTE. Data are no. (%) of patients, unless otherwise indicated. Characteristics describe patients from whom a baseline HIV-1 genotypic analysis was available. CDC Centers for disease control and prevention; IQR Interquartile ranges; MSM Men who have sex with men; TDRM Transmitted drug resistance mutations.